Genome Medicine (Oct 2022)

Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization

  • Anna C. F. Lewis,
  • Emma F. Perez,
  • Anya E. R. Prince,
  • Hana R. Flaxman,
  • Lizbeth Gomez,
  • Deanna G. Brockman,
  • Paulette D. Chandler,
  • Benjamin J. Kerman,
  • Matthew S. Lebo,
  • Jordan W. Smoller,
  • Scott T. Weiss,
  • Carrie L. Blout Zawatksy,
  • James B. Meigs,
  • Robert C. Green,
  • Jason L. Vassy,
  • Elizabeth W. Karlson

DOI
https://doi.org/10.1186/s13073-022-01117-8
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Background Polygenic risk scores (PRS), which offer information about genomic risk for common diseases, have been proposed for clinical implementation. The ways in which PRS information may influence a patient’s health trajectory depend on how both the patient and their primary care provider (PCP) interpret and act on PRS information. We aimed to probe patient and PCP responses to PRS clinical reporting choices Methods Qualitative semi-structured interviews of both patients (N=25) and PCPs (N=21) exploring responses to mock PRS clinical reports of two different designs: binary and continuous representations of PRS. Results Many patients did not understand the numbers representing risk, with high numeracy patients being the exception. However, all the patients still understood a key takeaway that they should ask their PCP about actions to lower their disease risk. PCPs described a diverse range of heuristics they would use to interpret and act on PRS information. Three separate use cases for PRS emerged: to aid in gray-area clinical decision-making, to encourage patients to do what PCPs think patients should be doing anyway (such as exercising regularly), and to identify previously unrecognized high-risk patients. PCPs indicated that receiving “below average risk” information could be both beneficial and potentially harmful, depending on the use case. For “increased risk” patients, PCPs were favorable towards integrating PRS information into their practice, though some would only act in the presence of evidence-based guidelines. PCPs describe the report as more than a way to convey information, viewing it as something to structure the whole interaction with the patient. Both patients and PCPs preferred the continuous over the binary representation of PRS (23/25 and 17/21, respectively). We offer recommendations for the developers of PRS to consider for PRS clinical report design in the light of these patient and PCP viewpoints. Conclusions PCPs saw PRS information as a natural extension of their current practice. The most pressing gap for PRS implementation is evidence for clinical utility. Careful clinical report design can help ensure that benefits are realized and harms are minimized.

Keywords